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CD8+ T cells infiltrating tumors are largely dysfunctional, but whether a subset maintains superior functionality remains 
ill defined. By high-dimensional single cell analysis of millions of CD8+ T cells from 53 individuals with lung cancer, we 
defined those subsets that are enriched in tumors compared with cancer-free tissues and blood. Besides exhausted and 
activated cells, we identified CXCR5+ TIM-3– CD8+ T cells with a partial exhausted phenotype, while retaining gene networks 
responsible for stem-like plasticity and cytotoxicity, as revealed by single cell sequencing of the whole transcriptome. Ex 
vivo, CXCR5+ TIM-3– CD8+ T cells displayed enhanced self-renewal and multipotency compared with more differentiated 
subsets and were largely polyfunctional. Analysis of inhibitory and costimulatory receptors revealed PD-1, TIG IT, and CD27 as 
possible targets of immunotherapy. We thus demonstrate a hierarchy of differentiation in the context of T cell exhaustion in 
human cancer similar to that of chronically infected mice, which is further shown to disappear with disease progression.
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Introduction
Despite the abundance of tumor-infiltrating lymphocytes (TILs) 
that has been associated with a better prognosis in several human 
cancers, the anti-tumor response mediated by immune cells is 
insufficient to induce tumor regression, mainly due to the po-
tent immunosuppression found in the tumor microenvironment 
(TME; Croci et al., 2007; Gajewski et al., 2013). Among TILs, the 
number, localization, and quality of cytotoxic CD8+ T cells have 
been shown to play a major role in this regard (Galon et al., 2013). 
Specifically, increased infiltration of CD8+ T cells displaying an 
effector phenotype and expressing killer molecules such as gran-
zyme B at the tumor invasive margin has been associated with 
favorable prognosis in colorectal (Pagès et al., 2005; Galon et al., 
2006; Bindea et al., 2013) and other types of cancer (Schumacher 
et al., 2001; Hamanishi et al., 2007; Ganesan et al., 2017). Immu-
nosuppression within the TME comprises several mechanisms 
that include, but are not limited to, the presence of suppressive 
populations such as tumor-associated macrophages/myeloid 
cells and CD4+ regulatory T cells, chronic antigenic stimulation, 
and inhibitory metabolites, cytokines, and ligands. All together, 
they generate a state of dysfunction in T cells also known as T cell 
exhaustion, characterized by poor proliferative capacity, dimin-
ished cytokine production and killing function, and increased 
expression of several inhibitory receptors on the cell surface 
(Wherry, 2011). Current immunotherapeutic strategies target-
ing inhibitory receptors such as Programmed Death-1 (PD-1) and 
Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) by blocking anti-
bodies reinvigorate T cells and further boost T cell infiltration, 
expansion, and effector functions (Leach et al., 1996; Freeman 
et al., 2000; Sharma and Allison, 2015; Wu et al., 2016; Wei et 
al., 2017), thus resulting in long-term disease stabilization or, in 
some cases, tumor regression. However, responses are only seen 
in a subset of patients (Hodi et al., 2010; Topalian et al., 2012; 
Jacquelot et al., 2017; Krieg et al., 2018), hence highlighting the 
need for improved strategies.
The CD8+ T cell compartment in peripheral blood and tissues 
is largely diverse, comprising several subsets with different de-
grees of specialization in phenotype, function, and gene expres-
sion (Mahnke et al., 2013; Farber et al., 2014). Recent application 
of high-content single cell technologies at the level of the whole 
transcriptome such as single cell RNA sequencing (scRNA-seq; 
Tirosh et al., 2016; Zheng et al., 2017) and cytometry by time-of-
flight (CyTOF; Chevrier et al., 2017; Lavin et al., 2017) suggested 
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that also CD8+ TILs are functionally heterogeneous, displaying 
different levels of T cell activation and exhaustion (Tirosh et 
al., 2016; Chevrier et al., 2017). Differential analysis of these 
states, which may coexist in the same T cell or be mutually ex-
clusive, led to the identification of new molecular regulators 
of exhaustion, such as the transcription factor GATA-3, which 
inhibits T cell effector function (Singer et al., 2017). Along the 
same lines, recent data obtained from chronically infected mice 
showed that the exhausted PD-1+ T cell compartment is orga-
nized in a hierarchy of differentiation, comprising less-dif-
ferentiated cells with intermediate levels of PD-1 (PD-1int) that 
retain self-renewal capacity and differentiation potential upon 
PD-1 blockade and PD-1 high (PD-1hi) cells that are terminally 
differentiated and functionally inefficient (He et al., 2016; Im et 
al., 2016; Leong et al., 2016; Utzschneider et al., 2016). This pre-
cursor–progeny relationship is reminiscent of that seen in the 
blood and lymphoid tissues in physiological situations, where 
CD8+ T memory stem cells (TSCM) are at the apex of the differ-
entiation program and are currently considered a major reser-
voir of long-term immunity (Gattinoni et al., 2011; Lugli et al., 
2013a; Fuertes Marraco et al., 2015; Oliveira et al., 2015; Akondy 
et al., 2017). Whether a stepwise differentiation program is also 
present in the context of T cell exhaustion in human tumors is 
still not clear.
In this study, 27-parameter flow cytometry applied to primary 
non-small cell lung cancer (NSC LC) samples, the adjacent can-
cer-free tissue and the blood enabled us to investigate millions of 
single CD8+ T cells and thus to identify rare immunophenotypes 
that are exclusively present within the tumor. In combination 
with scRNA-seq, we report the occurrence of stem-like CD8+ T 
cells that lack the canonical TSCM phenotype of circulating T cells. 
Rather, they simultaneously display a partial exhausted pheno-
type along with potent effector potential and enhanced self-re-
newal capacity. We further show that these CXCR5+ TILs are lost 
with disease progression.
Results
High-dimensional single cell analysis of NSC LC-infiltrating 
CD8+ T cells identifies tumor-enriched immunophenotypes
To better characterize the diversity occurring at the level of the 
CD8+ T cell compartment specifically within the tumor, we devel-
oped a polychromatic flow cytometry panel capable of simultane-
ously investigating 27 parameters on millions of single cells from 
resected tumor (n = 53), paired adjacent cancer-free lung tissue 
(hereafter referred to as “normal”; n = 45), and peripheral blood 
(n = 22) samples of treatment-naive, NSC LC patients (Fig. 1 A and 
Table 1). A list of the markers included in the panel, providing 
information on differentiation, activation, proliferation, and ex-
haustion status of T cells (see Mahnke et al., 2013), is reported in 
Table S1. Initial data representation with t-distributed stochastic 
neighboring embedding (tSNE), used to reduce the dimensional-
ity of the 27-parameter dataset (Amir et al., 2013), revealed that 
single cells from the three districts are substantially diverse in 
terms of their CD8+ T cell profile (Fig. 1 B, top row). To gain more 
insight on the immunophenotypes that preferentially character-
ize CD8+ T cells from the different specimens, we concatenated 
CD8+ T cell fluorescent data from all samples and analyzed them 
with Phenograph (Fig.  1  A), an unsupervised clustering algo-
rithm suitable for high-dimensional single cell data (Levine et al., 
2015). Phenograph identified 24 different CD8+ putative subpop-
ulations (“clusters;” visualized on top of the tSNE plot; Fig. 1 B, 
bottom row), whose frequencies are subsequently determined 
in each sample type. Hierarchical metaclustering of these data 
clearly separated blood and tumor specimens, indicating that 
they are substantially different at the high-dimensional single 
cell level (Fig. 1 C). Instead, normal tissues were split into two 
major groups that were more similar to either the blood or the 
tumor samples.
To define the phenotypic identity of immunophenotypes 
resulting from Phenograph clustering, we calculated the inte-
grated median fluorescence intensity (iMFI) values (Darrah et 
al., 2007) of each marker in each Phenograph cluster and visu-
alized values in a heat map, along with the median frequency 
of the same clusters in the blood, normal tissues, and tumor 
samples (Fig. 1 D). Hierarchical metaclustering of Phenograph 
clusters (rows) and markers (columns) grouped subpopula-
tions with similar immunophenotypes. Two of these clusters 
(1 and 3) were mostly present within the blood and displayed 
a phenotypic identity coincident with naive T cells, i.e., char-
acterized by high levels of CD45RA, CCR7, and CD27 and by 
the lack of multiple memory markers, such as CD95, PD-1, and 
T-bet. Other clusters, including 24, 14, 5, and 22, were virtually 
absent from blood while present in comparable abundance in 
both the normal tissue and tumor samples, indicating that they 
are lung-specific subsets. Despite displaying a common CD95+ 
CD27lo T-bet– memory phenotype, these were mainly character-
ized by variable levels of CD69 and CXCR3 expression, among 
others, thereby indicating tissue-residency (Wong et al., 2016). 
The abundance of these phenotypic clusters was counterbal-
anced by the absence of CD27int T-betint CD69– transitional mem-
ory cells (cluster 2) that instead are highly frequent in the blood. 
Importantly, the tumor lacked multiple subsets of CD45RA+/−
CCR7– terminal effector cells (clusters 18, 23, 4, and 8), charac-
terized by variable levels of CD57 and T-bet expression, that are 
known to be highly cytolytic, but replicative senescent (Takata 
and Takiguchi, 2006; Chattopadhyay et al., 2009; Mahnke et al., 
2013), leading us to conclude that the tumor is largely devoid 
of anti-tumor effectors. On the contrary, multiple clusters were 
specifically enriched in the tumor samples. These included both 
exhausted CD8+ T cell clusters 21, 13, and, to a lesser extent, 20, 
characterized by high expression of activation markers HLA-DR, 
CD25, and IRF4, and different combinations in expression of the 
inhibitory receptors PD-1, TIM-3, and TIG IT. Activated CD8+ T 
cell cluster 7, expressing only high levels of the activation mark-
ers, but not the proliferation marker Ki-67, was also enriched in 
lung tumors. Remarkably, Phenograph identified two memory 
clusters expressing CXCR5, i.e., 15 and 17, the latter featuring the 
highest expression. In addition, only the frequency of cluster 
17, characterized by a CD69+ PD-1int CD45RA– CCR7– effector-like 
phenotype, but lacking additional activation and exhaustion 
markers, was most different between the tumor and the adja-
cent lung tissue or the blood, suggesting this is a tumor-specific 
subpopulation (Fig. 1 D and Fig. S1).
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NSC LC tumors are enriched in CXCR5+ CD8+ T cells
It has been recently reported that chronically infected mice har-
bor, besides CXCR5– TIM-3+ CD8+ T cells that are exhausted and 
thus incapable of persisting in the long term, CXCR5+ TIM-3– 
CD8+ T cell progenitors that are PD-1int and, upon PD-1 blockade, 
are responsible for controlling chronic viral infections (He et al., 
2016; Im et al., 2016; Leong et al., 2016; Utzschneider et al., 2016; 
Wu et al., 2016). Therefore, these cells share phenotypic features 
with human CXCR5+ CD8+ TILs identified in Phenograph clus-
ters 15 and 17. We initially confirmed that results obtained with 
Phenograph clustering could be obtained by standard approaches 
and indeed found that CXCR5+ TIM-3– CD8+ T cells isolated by 
manual gating are enriched within tumors (Fig. 2, A and B), in-
dicating that unsupervised clustering of multidimensional single 
cell data are a reliable tool for the identification of phenotypically 
different subpopulations. In addition to the CXCR5+ TIM-3– and 
CXCR5– TIM-3+ CD8+ T cells, our manual analysis identified a 
third subset of CD8+ TILs lacking both CXCR5 and TIM-3 expres-
sion that is infrequent in chronically infected mice, indicating 
that human TILs are characterized by additional phenotypic 
complexity. As the major difference between clusters 15 and 17 
is not only CXCR5 abundance, but also expression of the tissue 
residency marker CD69, we next sought to determine to which 
extent CXCR5+ TIM-3– CD8+ T cells in tumors express CD69. The 
vast majority of these cells were CD69+ compared with those 
from normal tissue and blood samples (Figs. 2, C–E). Instead, 
CD69– CXCR5+ TIM-3– CD8+ T cells were relatively infrequent 
in both normal lung tissues and tumors, and their abundance 
decreased only slightly compared with blood (Fig. 2 F), thereby 
indicating that Phenograph overestimates the frequency of this 
phenotype. As a whole, lung cancer-infiltrating CXCR5+ CD8+ T 
cells were largely different compared with those from blood and 
the normal tissue at the phenotypic level, as they displayed a uni-
form CD45RA–CCR7–, effector memory-like phenotype, further 
characterized by increased expression of CD27 and PD-1, high 
levels of CXCR3, and lacking CD57 and T-bet (Fig. S1). In addition, 
CXCR5+ TIM-3– CD8+ T cells could be detected in primary col-
orectal carcinomas (1° colorectal carcinoma [CRC]; Fig. 2 G) and 
colorectal liver metastases (Fig. 2 H) at comparable frequencies, 
and, similarly to NSC LC-infiltrating TILs, they were for the vast 
majority CD69+.
We next determined how the CXCR5+ CD8+ TILs relate to 
other subpopulations within lung tumors. Pearson correlation 
analysis between the frequency of the CD69+ CXCR5+ cluster 17 
and the additional clusters identified by Phenograph revealed a 
significant negative correlation with cluster 7 (HLA-DR+ CD98hi 
activated cells), cluster 9 (Ki-67+ proliferating cells), and cluster 
13 (exhausted cells; Fig. 2 I). Confirming what was previously 
revealed by bioinformatic analysis, Ki-67 was poorly expressed 
by CXCR5+ CD8+ T cells as determined by manual gating, while 
it increased progressively in CXCR5– TIM-3– and CXCR5– TIM-3+ 
CD8+ TILs (Fig. 2, J and K). As a whole, tumor-infiltrating CXCR5+ 
CD8+ T cells are a quiescent population with hallmarks of tissue 
residency, but not of exhaustion and activation.
Single cell transcriptomics defines the memory identity and 
direct cytotoxic potential of CXCR5+ CD8+ T cells
Due to their enhanced self-renewal capacity and multipotency in 
the context of chronic infection, CXCR5+ CD8+ T cells resemble 
stem-like memory T cells (He et al., 2016; Im et al., 2016; Leong 
et al., 2016; Utzschneider et al., 2016). The presence of a popu-
lation with stem-like characteristics in human tumors accessi-
ble to PD-1 or, more in general, checkpoint blockade, would be 
extremely beneficial for the local anti-tumor immune response. 
Canonical human TSCM cells found in lymphoid tissues and circu-
lation bear a CD45RA+ CCR7+ CD27+ CD95+ phenotype (Zhang et 
al., 2005; Gattinoni et al., 2011; Lugli et al., 2013a) that is largely 
different from that of the identified CXCR5+ CD8+ TILs (Fig. 1 D). 
These TSCM cells were virtually absent in NSC LC TILs and in lung 
tissues (Fig. S2), indicating that the lung does not support their 
development or infiltration and subsequent maintenance. As 
mouse CXCR5+ CD8+ T cells highly respond to PD-1 blockade, we 
sought to determine whether human tumor-infiltrating CXCR5+ 
CD8+ T cells have shared features. The gene expression profile of 
CXCR5+ CD8+ T cells from chronically infected mice is similar to 
that of CD4+ T follicular helper (Tfh) cells and of CD8+ T cell mem-
ory precursors (He et al., 2016; Im et al., 2016; Leong et al., 2016; 
Utzschneider et al., 2016), suggesting they interact with B cells in 
lymphoid tissues and retain a long-lived memory potential, re-
spectively. Despite different tumor types having largely different 
biology, infiltrating CD8+ T cells share overlapping phenotypes, 
leading us to reason that a publicly available scRNA-seq dataset 
of CD45+ leukocytes isolated from melanoma patients could bet-
ter define the identity of CXCR5+ CD8+ T cells at the global tran-
scriptomic level (Tirosh et al., 2016). In this dataset, a total of 912 
cells were labeled as CD8+, of which 58 expressed CXCR5, thus 
comprising 6.4% of the melanoma-infiltrating CD8+ T cells, a fre-
quency similar to that of NSC LC-infiltrating CXCR5+ CD8+ T cells. 
Initial exploratory analysis by Pearson correlation between the 
expression of CXCR5 and of all the genes in the matrix revealed 
that transcripts typically present in long-lived memory T cells 
such as TCF7 (encoding TCF-1), WNT2, MYB, CD28, CCR7, BCL6, 
Figure 1. High-dimensional single cell analysis of tumor-infiltrating CD8+ T cells in NSC LC identifies tumor-enriched immunophenotypes. (A) Illus-
tration depicting the experimental workflow. Analysis is performed on peripheral blood (n = 22), normal lung tissue (n = 45), and tumor (n = 53) from NSC 
LC patients. Data were obtained in six independent experiments. (B) tSNE analysis of concatenated CD8+ T cells (3,000 cells/sample) from peripheral blood 
(n = 22), normal lung tissue (n = 45), and tumor (n = 53) samples from NSC LC patients (top panel) and color-coded tSNE map depicting clusters identified by 
Phenograph (bottom panel). (C) Hierarchical metaclustering (using Ward’s method) of the frequencies of the 24 Phenograph clusters in single blood (gray; n 
= 22), normal tissue (orange; n = 45), and tumor (purple; n = 53) samples. (D) Heat map showing the iMFI of specific markers in discrete Phenograph clusters 
identified in B. Phenograph clusters (rows) and markers (columns) are hierarchically metaclustered using Ward’s method to group subpopulations with similar 
immunophenotypes. The median frequency of each Phenograph cluster within the blood (n = 22), normal lung tissue (n = 45), and tumor (n = 53) samples 
are depicted by balloon plots. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 tumor versus blood and normal tissue samples; two-way ANO VA with 
Bonferroni post-hoc test.
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and SELL (encoding CD62L) are correlated with CXCR5 expres-
sion, while those present in exhausted or more differentiated 
effector CD8+ T cells such as HAV CR2 (encoding TIM-3), GZMB, 
PRF1, IFNG, and PRDM1 (encoding Blimp-1) are anti-correlated 
(Fig. 3 A). To confirm these results, we further subdivided CD8+ 
TILs from this dataset in three subsets based on CXCR5 and HAV 
CR2 expression levels. In particular, based on the combination of 
these two markers, we were able to identify cells that are CXCR5+ 
and express low levels of HAV CR2 (encoding TIM-3; see Materi-
als and methods), CXCR5– TIM-3–, and CXCR5– TIM-3+ T cells (re-
flecting those that were identified using flow cytometry). As the 
vast majority of CXCR5+ CD8+ T cells from melanoma expressed 
CD69 mRNA (Fig. S3 A), in line with protein data of lung tumors, 
we did not further subdivide between CD69– and CD69+ for the 
analysis of gene expression (Fig. 3 A). In this way, we confirmed 
the preferential expression of TCF7, EOM ES, BCL6, FOXO1, and 
CD28 by CXCR5+ T cells (Fig. 3, B and C) and revealing additional 
Tfh cell–associated genes such as SH2D1A (encoding SAP) and 
Ly9 (Fig. S3 B). Notably, a large proportion of these cells also 
expressed killer molecules such as GZMA, GZMK, GZMM, and 
PRF1 (the latter at slightly lower levels compared with CXCR5– 
TIM-3+). Importantly, the same cells expressed inhibitory recep-
tors such as PDCD1 (encoding PD-1) and TIG IT, albeit at lower 
levels compared with CXCR5– TIM-3+ CD8+ T cells, whereas 
they lacked LAG3 and CTLA4 (Fig. 3 C). Besides CD28, also co-
stimulatory receptors CD27 and TNF RSF9 (encoding 4-1BB) are 
expressed by CXCR5+ CD8+ T cells, yet the latter at a lower level 
compared with CXCR5– TIM-3+ cells. Overall, CXCR5– TIM-3– 
cells had a pattern of gene expression that is intermediate be-
tween these two subsets (Fig. 3, B and C).
Gene set enrichment analysis (GSEA) revealed significant 
overrepresentation of germinal-center CD4+ Tfh and CD8+ naive, 
but not CD8+ effector T cell gene signatures within the CXCR5+ 
compared with CXCR5– TIM-3+ CD8+ T cells (Fig. 3 D). Instead, 
naive and effector gene signatures where simultaneously more 
enriched when compared with CXCR5– TIM-3– (Fig. S3 C), further 
indicating that CXCR5+ CD8+ T cells have features of long-lived 
memory progenitors that are preferentially armed for effector 
functions. Most importantly, the genetic signature of murine 
CXCR5+ TIM-3– cells isolated from chronically infected mice as 
from Im et al. (2016) was highly enriched in human CXCR5+ TILs 
compared with CXCR5– TIM-3+ (Fig.  3  D) and CXCR5– TIM-3– 
CD8+ T cells (Fig. S3 C), further highlighting the similarity of 
human and murine subsets. In line with their follicular identity, 
the abundance of CXCR5+ TIM-3– CD8+ T cells positively cor-
related with that of CD4+ CXCR5+ (comprising Tfh cells) and, at 
a lesser extent, of CD19+ B cells within the tumor (Fig. S3, D–G). 
As expected, the frequency of CD4+ Tfh highly correlated with 
that of CD19+ B cells, confirming their mutual relationship also in 
lung cancer (Fig. S3 H). Several of the transcripts found differen-
tially expressed in melanoma-infiltrating CD8+ T cell subsets by 
scRNA-seq were then confirmed at the protein level in the NSC LC 
samples by using flow cytometry (TCF-1, Eomes, CD27, CD28, and 
PD-1; Fig. 3, E and F), thus further indicating that CXCR5+ CD8+ 
TILs share similar identity among different tumors. This flow 
cytometric analysis revealed additional differentially expressed 
markers that could not be measured by scRNA-seq due to low lev-
els of transcripts in all populations (unpublished data), including 
T-bet (lower in CXCR5+) and CXCR3 (higher in CXCR5+). Most no-
tably, CXCR3 is a signature marker of TSCM cells (Gattinoni et al., 
2011). Fig. S3 (I–K) additionally shows the phenotype of CD8+ TILs 
compared with naive (TN) and effector memory T (TEM) cells from 
the blood of a healthy donor, confirming that CXCR5+ TIM-3– 
cells coexpress markers of T cell precursors along with inter-
mediate expression of PD-1 and TIG IT. We conclude that CXCR5+ 
CD8+ TILs are armed for effector functions while retaining fea-
tures of memory cells and express molecules that are candidate 
for immunotherapeutic intervention, such as PD-1, TIG IT, and 
CD27, but not LAG-3, CTLA-4, or TIM-3.
Table 1. NSC LC patients’ characteristics
Parameter Subdivision Patients (n = 53)
Sex - no. (%) Female 27 (50.9)
Male 26 (49.1)
Age - mean (SD) 68 (8.2)
Smoking status - no. (%) Smoker 29 (54.7)
Former 17 (32.1)
Non-smoker 6 (11.3)
Unknown 1 (1.9)
Tumor type - no. (%) ADK lepidic 15 (28.3)
ADK solid & acinar 12 (22.6)
ADK papillary 8 (15.1)
ADK micropapillary 2 (3.8)
ADK mucinous 2 (3.8)
SSC 12 (22.6)
Other 2 (3.8)
pStage - no. (%) IA2 5 (9.4)
IA3 6 (11.3)
IB 7 (13.2)
IIA 4 (7.5)
IIB 15 (28.3)
IIIA 7 (13.2)
IIIB 6 (11.3)
IVA 2 (3.8)
Tumor location - no. (%) R 2 (3.8)
RLL 8 (15.1)
RML 2 (3.8)
RUL 15 (28.3)
RML+RLL 2 (3.8)
L 7 (13.2)
LLL 7 (13.2)
LUL 10 (18.9)
Results PET-CT scan 
available - no. (%)
Yes 33 (62.3)
No 20 (37.7)
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Figure 2. NSC LC tumors are enriched in CXCR5+ CD8+ T cells. (A) Representative dot plots showing manual gating analysis of CXCR5+ TIM-3–, CXCR5– TIM-3–, 
and CXCR5– TIM-3+ CD8+ T cells from a blood, normal lung tissue, and tumor sample. Numbers in the dot plots indicate the percentage of cells identified by 
the gates. (B) Summary of the frequency of CXCR5+ TIM-3– of CD8+ T cells from blood (n = 22), normal lung tissue (n = 45), and tumor (n = 53) samples as 
determined in A. Data were obtained in six independent experiments. (C) Representative dot plots showing CD69 expression by the CXCR5+ TIM-3– CD8+ T 
cells from a blood, normal lung tissue, and tumor sample. Numbers in the dot plots indicate the percentage of cells identified by the gates. (D–F) Summary of 
the frequency of CD69+ within CXCR5+ TIM-3– cells (D) and CD69+ CXCR5+ TIM-3– (E) and CD69– CXCR5+ TIM-3– within CD8+ T cells (F) from blood (n = 22), 
normal lung tissue (n = 45), and tumor (n = 53) samples, as determined in C. Data were obtained in six independent experiments. **, P < 0.01; ****, P < 0.0001; 
paired Wilcoxon t test. (G and H) Frequency of CXCR5+ TIM-3– (G) and CD69+ expression in CXCR5+ TIM-3– (H) CD8+ T cells in primary CRC (1°CRC; n = 6) and 
colorectal liver metastasis (Liver met; n = 7). Data are obtained in one experiment and are shown as mean ± SEM. (I) Pearson correlation between the frequency 
of Phenograph cluster 17 (CD69+ CXCR5+) with cluster 7 (HLA-DR+ CD98hi activated cells), cluster 9 (Ki-67+, proliferating cells), and cluster 13 (exhausted cells). 
P values are shown in each panel. (J) Representative dot plots showing Ki-67 expression by the indicated CD8+ T cell subsets from a tumor sample. Numbers 
in the dot plots indicate the percentage of cells identified by the gates. (K) Summary of the frequency of Ki-67+ cells within the indicated CD8+ T cell subsets 
from all tumor samples (n = 53), as determined in J. ****, P < 0.0001; paired Wilcoxon t test. Data were obtained in six independent experiments.
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Tumor-infiltrating CXCR5+ CD8+ T cells have rapid effector 
functions and are polyfunctional
We next sought to determine whether the lack of IFNG, GZMH, 
and GZMB would result in decreased effector functions by 
CXCR5+ CD8+ TILs compared with other subsets. All sort-purified 
T cell subsets rapidly produced IFNγ, IL-2, TNF cytokines, and the 
degranulation marker CD107a upon PMA/ionomycin stimulation 
ex vivo (Fig. 4, A and B). In line with their exhausted phenotype, 
CXCR5– TIM-3+ were the less functional in this regard, while 
CXCR5+ TIM-3– expressed the highest level of CD107a (Fig. 4 B). 
Combinatorial analysis revealed the preferential coproduction 
of the four effector molecules by CXCR5+ TIM-3– compared with 
both CXCR5– TIM-3– and CXCR5– TIM-3+ cells (Fig. 4, C and D). 
These data indicate that CXCR5+ TIM-3– CD8+ TILs retain rapid 
effector functions ex vivo and display enhanced polyfunctional-
ity compared with other TIL subsets.
Tumor-infiltrating CXCR5+ CD8+ T cells are endowed with 
enhanced stemness
We next tested whether NSC LC-infiltrating CXCR5+ CD8+ T cells 
retain enhanced stem cell–like properties as suggested by their 
molecular signature. A hallmark of human memory stem cells is 
their capability to generate more effector progeny while self-re-
newing. Therefore, we sort-purified CXCR5+ TIM-3–, CXCR5– 
TIM-3–, and CXCR5– TIM-3+ CD8+ T cells from tumor samples 
by flow cytometry (Fig. 5 A) and stimulated them with αCD3/28 
antibody-conjugated beads in combination with IL-2 and IL-15 
or IL-15 alone to determine their multipotency and self-renewal 
capabilities, respectively (Gattinoni et al., 2011). Fig. 5 (B and D) 
shows that CXCR5+ TIM-3– and CXCR5– TIM-3– cells proliferated 
more vigorously than CXCR5– TIM-3+ cells in response to TCR 
stimulation. These proliferating subsets displayed high levels 
of HLA-DR and CD25 activation markers and low levels of CD27 
and CD28 (Fig. 5 K and Fig. S4), suggesting further differentia-
tion. In line with murine data of adoptively transferred T cells 
in hosts bearing a chronic infection, only CXCR5+ TIM-3– cells 
were able to generate all subsets of T cells identified by combi-
nations of CXCR5 and TIM-3 expression (Fig. 5, E and H), thereby 
suggesting multipotency. In addition, these cells displayed lower 
levels of TIM-3 on the cell surface compared with other subsets 
(Fig. 5 G). CXCR5+ TIM-3– proliferated more than CXCR5– TIM-3+ 
cells also in response to IL-15 (Fig. 5 D). A similar trend could 
be seen for CXCR5– TIM-3–, although not reaching statistical sig-
nificance. Importantly, the three subsets generated progenies 
with dramatic differences at the phenotypic level. While CXCR5+ 
TIM-3– largely retained their original phenotype (Fig. 5, F and 
I), characterized by high levels of CD27 and CD28 costimulatory 
molecules and low levels of CD45RA (Fig. 5 L and Fig. S4), pro-
liferating CXCR5– TIM-3– cells, the vast majority of which was 
CD45RA– upon ex vivo purification, displayed high levels of 
CD45RA and, at a lesser extent, TIM-3, indicating differentiation 
toward the terminal effector phenotype (Fig. 5, J and L; and Fig. 
S4). Most notably, CXCR5 could not be detected in these cells, as 
well as in CXCR5– TIM-3+ exhausted cells in response to IL-15, 
hence confirming the unidirectional CXCR5+ to CXCR5– con-
version. Thus, the tumor-infiltrating CXCR5+ CD8+ T cells have 
features of multipotency and stemness, as previously described 
for circulating TSCM cells, in response to TCR-dependent and ho-
meostatic stimulation, respectively.
Loss of CXCR5+ CD8+ TILs with lung cancer disease progression
The enhanced stemness of the tumor-infiltrating CXCR5+ CD8+ T 
cells suggest that these cells might be beneficial for the anti-tumor 
CD8+ T cell response, but their role in disease progression is still 
not defined. The maximum standardized uptake value (SUVmax), 
as obtained from positron emission tomography (PET) before sur-
gery, is an indicator of the glycolytic capacity of the tumor and is 
considered a negative prognostic parameter for NSC LC (Takeuchi 
et al., 2014; Liu et al., 2016; Lopci et al., 2016). Indeed, patients with 
a pathological stage (pStage) I tumor, defined according to the in-
ternational TNM classification, displayed a lower SUVmax com-
pared with patients with pStage II or III in our cohort (Fig. 6 A). 
Therefore, we divided patients in two groups on the basis of the 
median value for this parameter across the entire cohort (high 
and low groups) for which both PET values and high-dimen-
sional single cell profiling data were available (n = 33). We next 
determined the frequency of cluster 17 (i.e., CD8+ T cells with a 
preferential CD69+ CXCR5+ phenotype) in the tumor samples and 
revealed that this cluster is more prevalent in low glycolytic tu-
mors (Fig. 6 B). Accordingly, we found that the same subpopulation 
was more prevalent within NSC LC samples of patients with early 
versus late disease stage (Fig. 6 C). In conclusion, the abundance 
of CXCR5+ CD8+ T cells in the tumor negatively correlates with dis-
ease progression.
Discussion
We applied high-dimensional single cell approaches to analyze 
the tumor-infiltrating CD8+ T cells and define those phenotypic 
subpopulations that are preferentially enriched within the tumor 
Figure 3. Single cell transcriptomics defines the early differentiated memory identity and cytotoxic potential of CXCR5+ CD8+ T cells. (A) Pearson cor-
relation analysis of CXCR5 profile-correlated genes in the public available scRNA-seq dataset from metastatic melanoma-infiltrating CD8+ T cells (n = 912) from 
Tirosh et al. (2016). (B) Heat map depicting the Z score of expression values of genes that characterize melanoma-infiltrating CXCR5+ (n = 58), CXCR5– TIM-3– (n 
= 278), and CXCR5– TIM-3+ (n = 297) CD8+ T cells from the same dataset as in A. (C) Violin plots showing expression probability distributions of indicated genes 
within the infiltrating CXCR5+ (n = 58), CXCR5– TIM-3– (n = 278), and CXCR5– TIM-3+ (n = 297) CD8+ T cells, as defined in B. *, P < 0.05; Wilcoxon rank sum test. 
(D) GSEA of the infiltrating CXCR5+ versus CXCR5– TIM-3+ CD8+ T cells for the indicated gene sets. ES, enrichment score; NES, normalized enrichment score; 
FDR, false discovery rate. (E) Representative histograms depicting expression of different markers on tumor-infiltrating CXCR5+ TIM-3–, CXCR5– TIM-3–, and 
CXCR5– TIM-3+ CD8+ T cells as determined by flow cytometry. (F) Summary of the results shown in C. All MFIs refer to marker expression in bulk populations 
identified by CXCR5 and TIM3 expression, except for PD-1, where MFI refers to the PD-1+ fraction. All graphs show measurements from 53 donors obtained in 
six independent experiments, except for TCF-1 (n = 16; four independent experiments) and CD28 (n = 13; three independent experiments). *, P < 0.05; ***, P < 
0.001; ****, P < 0.0001; paired Wilcoxon t test.
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Figure 4. CXCR5+ TIM-3– CD8+ T cells are efficient in rapidly producing effector molecules. (A–D) Sorted CXCR5+ TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+ 
CD8+ TILs were stimulated for 3 h with PMA/ionomycin, and CD107a expression and cytokine production was determined by flow cytometry (n = 7; all per-
formed in independent experiments). (A) Representative dot plots showing the analysis of IL-2, TNF, and IFNγ production by NSC LC tumor-infiltrating CXCR5+ 
TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+ CD8+ T cells following short-term PMA/ionomycin stimulation. Numbers in the dot plots indicate the percentage 
of cells identified by the gates. (B) Representative histograms showing the expression of CD107a by the indicated subsets after short-term PMA/ionomycin 
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compared with the blood and the adjacent cancer-free tissue. We 
adopted a novel flow cytometry technology capable to investigate 
27 parameters simultaneously in millions of single T cells, a num-
ber still difficult to reach by CyTOF or scRNA-seq due to through-
put and cost, respectively, and thus were able to identify also 
those rare subsets that are present in the TME. Specifically, we 
focused on CD8+ T cells that are amenable to immune checkpoint 
blockade (i.e., those that have traits of exhaustion) while retain-
ing functional capacity, so to exploit their enhanced anti-tumor 
response. In this way, we revealed the presence of a subset of 
CD8+ T cells featuring a CXCR5+ TIM-3– phenotype, long-lived 
memory characteristics, CD4+ Tfh-shared gene expression, and 
enhanced stem cell–like properties when compared with more 
differentiated subsets at the same site. The presence of these T 
cells exclusively in the TME is accompanied by increased fre-
quencies of activated and exhausted phenotypes at the expense 
of CD27+ memory T cells and highly cytolytic, CD45RA+ T cells, 
which instead are normally abundant within the adjacent can-
cer-free lung tissue from the patient (Fig. 1 D). Our high-dimen-
sional analysis identified a subset of nonneoplastic lung tissues 
that was more similar to blood samples rather than the tumors, 
possibly suggesting contamination from the circulating blood. 
Despite not being formally excluded, this is considered to be 
minor given the virtual absence of true naive cells (clusters 1 
and 3) along with the presence of CD45RAint/+ CCR7– CD57+ phe-
notypes (clusters 18, 23, 4, and 8) that are normally abundant in 
lung tissues from healthy individuals (Thome et al., 2014) and of 
additional subsets that are rare in the blood (clusters 24, 14, 5, and 
22). Overall, our data further confirm that the tumor is largely 
devoid of subpopulations capable to kill in an effective way, while 
supporting features of T cell exhaustion since the early disease 
stage. These results are in line with the recent characterization of 
a cohort of 73 renal cell carcinoma patients and a smaller cohort 
of 18 NSC LC patients by CyTOF, where patients at different stages 
of the disease were characterized by similar immune signatures 
at the level of T cells, including that of T cell exhaustion (Chevrier 
et al., 2017; Lavin et al., 2017).
The CXCR5+ population described here is the human equiv-
alent of the partially exhausted, CXCR5+ PD-1int CD8+ T cells 
expressing the transcription factor TCF-1, that, in chronically 
infected mice, are preferentially responsible for viral control 
following PD-1 blockade (He et al., 2016; Im et al., 2016; Leong 
et al., 2016; Utzschneider et al., 2016; Wu et al., 2016). Although, 
we could not directly address this enhanced responsiveness to 
PD-1 blockade by the tumor-infiltrating CXCR5+ CD8+ T cells 
due to practical reasons (i.e., low number of cells obtained 
after sorting), the flow cytometry and scRNA-seq data support 
this concept. By scRNA-seq of melanoma TILs and subsequent 
validation by high-dimensional flow cytometry and functional 
assays in lung TILs, we confirmed the follicular identity, a dif-
ferentiation pattern similar to that of long-lived memory T cells, 
and partial exhaustion of single CXCR5+ CD8+ T cells and addi-
tionally revealed the simultaneous coexistence of stem cell–like 
behavior, polyfunctional effector molecule production, and cy-
totoxic potential. This is important because immune activation 
will result in immediate effector functions that can persist in 
the long term. Stem-like properties of T cells were shown to be 
beneficial in multiple instances, such as in the context of adop-
tive cell transfer where long-lived memory T cells are generally 
associated with superior anti-tumor responses (Gattinoni et al., 
2005, 2011; Chapuis et al., 2013). Although CXCR5+ CD8+ T cells 
display a maturation phenotype that is largely different from that 
of canonical TSCM cells, i.e., CD45RA– CCR7–, effector memory-like 
with tissue-resident characteristics, they also share some TSCM 
properties, including the expression of CD27, CD28 and CXCR3 
surface markers, and Eomes, but not T-bet transcription factors, 
self-renewal, and multipotency (Gattinoni et al., 2011; Lugli et al., 
2013a; Fuertes Marraco et al., 2015; Oliveira et al., 2015; Pilipow et 
al., 2015; Akondy et al., 2017). Moreover, only CXCR5+ CD8+ TILs 
express TCF-1, a master regulator of persistence that is critical 
for the formation and maintenance of these cells in chronically 
infected mice. Despite acknowledging the limitations of in vitro 
assays to define a precursors–progeny relationship in humans, 
our data support the concept that a hierarchy of differentiation 
is also present at the tumor level in the context of exhaustion, 
albeit featuring different players, i.e., less differentiated CXCR5+ 
TIM-3– stem-like CD8+ T cells giving rise to CXCR5– and TIM-3+ 
effector subsets upon triggering of the TCR.
Fine mapping of the expression of inhibitory and costimula-
tory receptors with single cell resolution by both flow cytometry 
and scRNA-seq indicated that PD-1 and TIG IT could be prefer-
ential targets of immunotherapy with checkpoint inhibitors, 
while CD27 with immunostimulating antibodies favor effector 
differentiation (Ahrends et al., 2016). Differently, blockade di-
rected to LAG-3 and CTLA-4, which are present on CXCR5+ CD8+ 
T cells from chronically infected mice, but are poorly expressed on 
human CXCR5+ CD8+ TILs, would be relatively inefficient. Despite 
not being formally demonstrated due to the difficulty in identi-
fying tumor antigens, the presence of traits of exhaustion and 
the accumulation exclusively within tumors suggest that CXCR5+ 
CD8+ TILs are tumor-specific. It is at the moment unclear why 
CXCR5+ CD8+ T cells mainly form/accumulate in the TME com-
pared with the cancer-free lung. Their follicular cell identity and 
their positive correlation with the abundance of Tfh and B cells 
within the tumor suggest they localize at the border of B cell areas 
in tertiary lymphoid structures, which have been shown in mul-
tiple instances to be associated with enhanced effector responses 
and increased survival in lung cancer (Dieu-Nosjean et al., 2008).
In conclusion, CXCR5+ CD8+ TILs are the ideal cells to be re-
lieved from suppression as they serve as precursors of more 
stimulation. Numbers in the histograms indicate the percentage of cells identified by the gates. (C) Pie charts representing the proportion of CXCR5+ TIM-3–, 
CXCR5– TIM-3–, and CXCR5– TIM-3+ CD8+ TILs expressing and producing different combinations of CD107a, IL-2, IFNγ, and TNF after PMA/ionomycin stimulation 
(n = 7). Frequencies were corrected by background subtraction as determined in unstimulated controls. **, P < 0.01; ***, P < 0.001; partial permutation tests, 
using SPI CE software. (D) Frequency of CXCR5+ TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+ CD8+ TILs expressing and producing different combinations of 
CD107a, IL-2, IFNγ, and TNF after PMA/ionomycin stimulation (n = 7). Data are given as mean ± SEM. *, P < 0.05 versus CXCR5+ TIM-3– CD8+ TILs; +, P < 0.05 
versus CXCR5– TIM-3– CD8+ TILs, paired Wilcoxon t test.
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Figure 5. Tumor-infiltrating CXCR5+ CD8+ T cells are endowed with enhanced stemness. (A) Representative dot plots depicting the purity of sorted 
CXCR5+ TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+ CD8+ T cells from a NSC LC tumor sample. Numbers in the dot plots indicate the percentage of cells iden-
tified by the gates. (B–L) Sorted CFSE-stained CXCR5+ TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+ CD8+ T cells were stimulated with αCD3/CD28 beads in 
combination with IL-2 and IL-15 (10 ng/ml, each) for 6 d (n = 9; all performed in independent experiments) to determine effector differentiation or with IL-15 (50 
ng/ml) for 11 d (n = 7; performed in six independent experiments) to determine their self-renewal capacity. As a non-proliferating negative control, cells were 
kept in 1 ng/ml IL-15. (B and C) Representative histograms showing CFSE dilution in sorted subsets after αCD3/CD28 + IL-2/IL-15 (B) or IL-15 (C) stimulation. 
(D) Summary of the proliferation index, calculated as MFI non-proliferating fraction / MFI proliferating fraction × % cells with diluted CFSE, after αCD3/CD28 
+ IL-2/IL-15 (n = 9) or IL-15 (n = 7) stimulation normalized for the value obtained for the CXCR5+ TIM-3– subset. Data are given as mean ± SEM; **, P < 0.01; 
paired Wilcoxon t test. (E and F) Representative dot plots depicting the expression of CXCR5 and TIM-3 by the proliferated cells of the different sorted subsets 
after αCD3/CD28 + IL-2/IL-15 (E) or IL-15 (F) stimulation. Numbers in the dot plots indicate the percentage of cells identified by the gates. (G) TIM-3 MFI of 
the proliferating cells (CFSE diluted) of the different sorted subsets after αCD3/CD28 + IL-2/IL-15 stimulation (n = 9). Data are given as mean ± SEM; paired 
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differentiated effectors with enhanced functionality and per-
sistence. However, they tend to be lost with disease progression. 
More differentiated CXCR5– TIM-3– CD8+ T cells retain some 
degree of functionality following stimulation despite their de-
creased self-renewal and degranulation potential and may serve 
as precursors of effector cells upon PD-1 blockade in advanced 
disease. However, this phenotype is poorly represented in the 
murine antigen-specific CD8+ T cell pool generated following 
chronic infection (He et al., 2016; Im et al., 2016; Leong et al., 
2016; Utzschneider et al., 2016; Wu et al., 2016), thus raising the 
question whether tumor-specific CD8+ T cells are contained in 
the CXCR5– TIM-3– subset and can be primed intratumorally. 
Future studies should address whether tumor antigen-specific 
stem-like cells also exist in lymphoid tissues, and whether they 
are an additional reservoir of anti-tumor T cell responses.
Materials and methods
Study design
All human experiments were approved by the Humanitas Clin-
ical and Research Center Internal Review Board (approval nos. 
1501, 1021, and 168/18). All patients provided written informed 
consent. In this research, we included 53 patients with diagnosis 
of NSC LC with clinical stage I or II who underwent a lung major 
resection (anatomical segmentectomy, lobectomy, or pneumo-
nectomy) plus radical lymph node dissection with radical intent 
at the Humanitas Cancer Center. Tumor (n = 53) and adjacent 
cancer-free lung tissue samples from the same surgical speci-
men (n = 45) were obtained in the operating room in a sterile 
field by the surgeon while blood sample collection (10 ml; n = 
22) were obtained by venipuncture at induction of anesthesia. 
Human intestinal specimens were obtained from patients with 
CRC undergoing resection surgery and liver tumor tissues from 
patients undergoing hepatectomy for hepatic metastatic disease 
from CRC. None of patients received preoperative chemotherapy 
or radiotherapy. Details on the patients’ characteristics are indi-
cated in Table 1. Information on the pathological stage (pStage), 
determined by an institutional pathologist (some patients were 
restaged as III following examination of the tumor), was available 
for all patients, while results of the preoperative fluorodeoxy-
glucose (FDG) PET–computed tomography (CT) scan were avail-
able for 33 patients. PET scans were acquired ∼60 min after FDG 
administration in patients fasting for at least 6 h. Whole body 
images were obtained from the base of the skull to mid-thigh by 
means of integrated PET-CT tomographs. Reconstructed images 
were displayed on a GE ADW4.6 workstation (GE Healthcare). 
SUVmax was determined as the highest pixel value within the 
tumor mass that was identified with three-dimensional volumes 
of interest, as previously described (Lopci et al., 2016). SUVmax 
high and low groups (Fig. 6) were defined as those patients whose 
tumors have values that are above or below the median of the 
distribution, respectively.
Sample collection and processing
Blood samples were collected in Vacutainer EDTA Tubes (BD), 
while the tumor and normal tissue samples were collected in 
RPMI-1640 medium supplemented with 10% FBS (Sigma-Aldrich), 
1% penicillin-streptomycin, and 1% Ultra-glutamine (both from 
Lonza), hereafter referred to as R10. Peripheral blood mononu-
clear cells were isolated from the blood samples or from healthy 
donors (buffy coats) by Lympholyte-H (Cedarlane) density sepa-
ration and frozen in liquid nitrogen according to standard proce-
dures, as described previously (Lugli et al., 2013b). The tumor and 
normal tissue samples were processed into single cell suspensions 
by mechanical disaggregation. The samples were cut into small 
fragments in a size of ∼1 mm3, after which further disaggregation 
was performed using gentleMACS dissociator (Miltenyi Biotec). 
Subsequently, samples were passed through a 70-µm cell strainer 
(Falcon) and washed with physiological saline solution (NaCl 0.9%; 
Baxter). After centrifugation (300 g, 15 min), erythrocytes lysis 
was performed by incubating the cell suspension for 5 min in ACK 
lysis buffer (made in house; 155 mM NH4Cl, 10 mM KHCO3, and 
0.1 mM EDTA-2Na [all from Sigma-Aldrich] diluted in H2O), and 
washed again with saline. CRC samples were mechanically minced 
in small pieces, washed in HBSS without Ca2+and Mg2 (Lonza) 
supplemented with 1% penicillin/streptomycin/amphotericin 
(Invitrogen) and followed enzymatic digestion with 1.5 µg/ml of 
collagenase IV (Life Technologies), 20 µg/ml of hyaluronidase, and 
50 µg/ml of DNase (both from Sigma-Aldrich) for 2 h at 37°C/5% 
CO2. Lymphocytes were separated by 30%/70% Percoll gradient 
centrifugation. Liver metastasis were cut in small pieces followed 
by enzymatic digestion in gentleMACS dissociator with 2 mg/ml 
collagenase D (Roche Diagnostic) for 45 min at 37°C/5% CO2. Lym-
phocytes were isolated by 30%/70% Percoll density gradient. The 
cells were either frozen in liquid nitrogen according to standard 
procedures or, in case of sorting by flow cytometry, NSC LC leu-
kocytes were further purified by centrifugation (790 g for 30 min 
without brake) on a 40%/70% Percoll (Sigma-Aldrich) gradient. 
After isolation of the interphase between the two layers, the cells 
were washed with HBSS without Ca2+ or Mg2+ (Lonza) and stained 
with fluorescently conjugated monoclonal antibodies (mAbs).
Polychromatic flow cytometry for the detection of surface and 
intracellular antigens
For the ex vivo immunophenotyping experiments, frozen sam-
ples were used and were thawed in R10 supplemented with 20 
µg/ml DNase I from bovine pancreas (Sigma-Aldrich). After 
extensive washing with PBS (Sigma-Aldrich), the cells were 
stained immediately with the Zombie Aqua Fixable Viability kit 
(BioLegend) for 15 min at room temperature. Then, the cells were 
Wilcoxon t test. (H and I) Percentage of CFSE diluted cells with a given phenotype following stimulation with αCD3/CD28 + IL-2/IL-15 (H; n = 9) or IL-15 (I; n = 
7). Data are given as mean ± SEM. Horizontal bars indicate significant comparisons. Bar colors refer to progenies with specific phenotypes as indicated in the 
legend. Paired Wilcoxon t test. (J) Representative dot plots showing CD45RA expression and CFSE dilution by IL-15–stimulated cells. Numbers in the dot plots 
indicate the percentage of cells identified by the gates. (K and L) Heat maps showing the median frequency of the indicated markers by the different αCD3/
CD28 + IL-2/IL-15 (K; n = 9) or IL-15 (L; n = 7) stimulated CD8+ T subsets. NP, non-proliferating cells from the negative control; P, proliferating cells (CFSE diluted) 
after stimulation. Comparisons that are statistically significant are indicated in Fig. S4. *, P < 0.05.
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washed and stained with the combination of mAbs purchased 
from either BD Biosciences, BioLegend, or eBioscience, as listed 
in Table S1. mAbs were previously titrated to define the optimal 
concentration, as described (Lugli et al., 2013b). Chemokine re-
ceptors were stained for 20 min at 37°C, while all other surface 
markers (except CD3) were stained for 20 min at room tempera-
ture. Intracellular detection of CD3, Ki-67, and transcription fac-
tors was performed following fixation of cells with the FoxP3/
transcription factor staining buffer set (eBioscience) according 
to manufacturer’s instructions and by incubating with specific 
mAbs for 30 min at 4°C.
In parallel, all samples were stained with a panel of mAbs di-
rected to reveal the major immune populations, such as T cells 
(CD3+), B cells (CD19+), myeloid (CD11b+), and NK subsets (CD16, 
CD56, and NKp46). Additional panels used for further character-
izing the CXCR5+ CD8+ T cell subset are listed in Table S1. Stain-
ings were performed as described above, except for intracellular 
staining of TCF-1, for which cells were fixed with Transcription 
Factor Buffer set (BD Biosciences) according to the manufactur-
er’s instructions. For detection of cytokines, cells were fixed with 
BD Cytofix/Cytoperm Fixation/Permeabilization Solution kit 
(BD Biosciences) according to the manufacturer’s instructions. 
CD107a-specific antibody was added in the culture medium 
during the stimulation.
All data were acquired on a FACS Symphony A5 flow cytom-
eter (BD Biosciences) equipped with five lasers (UV, 350 nm; 
violet, 405 nm; blue, 488; yellow/green, 561 nm; red, 640 nm; 
all tuned at 100 mW, except UV tuned at 60 mW) and capable to 
detect 30 parameters. Flow cytometry data were compensated 
in FlowJo by using single stained controls (BD Compbeads incu-
bated with fluorescently conjugated antibodies), as described 
(Lugli et al., 2017).
High-dimensional flow cytometry data analysis.
Flow Cytometry Standard (FCS) 3.0 files were imported into 
FlowJo software version 9, and analyzed by standard gating to 
remove aggregates and dead cells, and identify CD3+ CD8+ T cells. 
3,000 CD8+ T cells per sample were subsequently imported in 
FlowJo version 10, biexponentially transformed, and exported for 
further analysis in R (version 3.3.3) by a custom-made script that 
makes use of Bioconductor libraries and R statistical packages. 
Blood, normal lung tissue, and tumor samples were labeled with 
a unique computational barcode for further identification and 
concatenated in a single matrix by using the “cytof_exprsMerge 
function” (Chen et al., 2016). Data were analyzed using the Phe-
nograph algorithm coded in the cytofkit package (version 1.6.5; 
Chen et al., 2016). Parameter K, indicating the number of nearest 
neighbors identified in the first iteration of the algorithm, was 
set at 60. Phenograph clusters were visualized using tSNE (cy-
tofkit package, with default parameters). Clusters representing 
<0.5% were disregarded in subsequent analysis. The data were 
then reorganized and saved as new FCS files, one for each clus-
ter, that were further analyzed in FlowJo to determine the fre-
quency of positive cells for each marker and the corresponding 
MFI. These values were multiplied to derive the integrated MFI 
(iMFI, rescaled to values from 0 to 100; Fig. 1 D). The heat map, 
showing the iMFI of each marker per cluster, and the subsequent 
metaclustering was performed using the gplots R package. Hier-
archical metaclustering of all samples, based on the frequency of 
Phenograph clusters (Fig. 1 C), was performed in R based on the 
Euclidean distance and Ward-linkage.
scRNA-seq data processing and in silico sorting of 
CD8+ T cell subsets
Normalized scRNA-seq counts were downloaded from Gene 
Expression Omnibus dataset (GSE72056). Analysis was re-
stricted to the cells labeled as “T cells,” as previously defined 
by Tirosh et al. (2016). T cells were separated into CD4+ and 
CD8+ based on the normalized expression levels (E) of CD4 (E 
> 4), and CD8 (average of CD8A and CD8B, E > 4). The correla-
tion between the expression profile of CXCR5 in the CD8+ TILs 
(n = 912), and that of all other genes present in the matrix was 
calculated using the “cor.test” function in R with Pearson as 
correlation methods. The CD8+ TILs (n = 912) were further di-
vided in three groups based on CXCR5 and HAV CR2 (encoding 
TIM-3) expression levels. Specifically, we identified T cells that 
were CXCR5+ (E > 0; including all cells irrespectively of HAV CR2 
expression, which was negligible in this subset; unpublished 
data), CXCR5– TIM-3+ (E = 0 and E ≥ 5.930667, respectively), and 
CXCR5– TIM-3– (E = 0 and E ≤ 2.1527, respectively). Thresholds 
of HAV CR2 (TIM-3) expression were determined by calculating 
the 33.3 and 66.7 percentile of the HAV CR2 mRNA distribution. 
Therefore, if HAV CR2 mRNA levels were <33.3 percentile, cells 
were labeled as CXCR5– TIM-3–; otherwise, if >66.7 percentile, 
as CXCR5– TIM-3+. Differentially expressed genes in each pair-
wise comparison of CD8+ T cell subsets were determined by the 
“FindMarkers” function coded in the Seurat R package (version 
2.1.0; Satija et al., 2015) with default parameters except for the 
Figure 6. Loss of CXCR5+ CD8+ TILs with lung cancer 
disease progression. (A) SUVmax values among NSC LC 
patients with pStage I (n = 24), II (n = 15), or III (n = 15); *, P 
< 0.05; **, P < 0.01; Mann-Whitney t test. (B) Based on the 
SUVmax values, samples were divided into SUVmax low and 
high with the median SUVmax value as cut-off. Frequency 
of Phenograph cluster 17 (CD69+CXCR5+) is depicted in the 
SUVmax low (n = 17) and high (n = 16) groups. *, P < 0.05; 
Mann-Whitney t test. (C) Frequency of Phenograph cluster 
17 (CD69+CXCR5+) in tumor samples from patients with 
NSC LC pStage I (n = 19) versus II-IVA (n = 34). *, P < 0.05; 
Mann-Whitney t test. Data were obtained in six independent 
experiments. *, P < 0.05; **, P < 0.01; Mann-Whitney t test.
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“logfc.threshold” that was set equal to 0. Subset-specific genes 
were defined as up-regulated in the pairwise comparisons be-
tween a cell subset and the other two. In this way we obtained 
555, 46, and 1 specific gene for the CXCR5+, CXCR5– TIM-3+, 
and CXCR5– TIM-3– populations, respectively. The heat map 
shown in Fig. 3 B was generated by using the “DoHeatmap” func-
tion coded in the Seurat R package (for the CXCR5+ subset, only 
the first 100 differentially expressed genes with the highest fold 
change resulting from the comparison with the CXCR5– TIM-3+ 
or CXCR5– TIM-3– CD8+ T cells are shown). Violin plots, depict-
ing the gene expression probability distributions across subsets, 
were obtained with the Seurat R package.
Microarray data analysis
Microarray probe fluorescence signals of the publicly avail-
able dataset GSE84105 (sample IDs used for this analysis: 
GSM2227309, GSM2227310, GSM2227311, GSM2227312, 
GSM2227313, and GSM2227314) were converted to expression 
values using robust multiarray average procedure RMA (Irizarry 
et al., 2003) of Bioconductor affy package. Specifically, fluores-
cence intensities were background adjusted, normalized using 
quantile normalization and log2 expression values for a total of 
18,075 custom probe sets calculated using median polish summa-
rization and custom chip definition files for Affymetrix Mouse 
Genome 430 2.0 arrays based on Entrez genes (Mouse4302_Mm_
ENT REZG version 21.0.0). To identify genes that are differen-
tially expressed, we compared the expression profiles of CXCR5+ 
TIM-3– versus CXCR5– TIM-3+ samples using limma algorithm 
coded in the same R package (Ritchie et al., 2015). By setting 
the false discovery rate and fold change thresholds at 0.05 and 
2, respectively, we obtained 246 differentially expressed genes. 
Mouse Entrez IDs were converted in the corresponding human 
homologous genes using the HUGO Gene Nomenclature Commit-
tee database, and they were subsequently used for GSEA.
GSEA
Over-representation analysis was performed using the GSEA 
tool described in Subramanian et al. (2005). GSEA was applied 
on the entire list of genes that compose the single cell RNaseq ex-
pression matrix (GSE72056). Genes were ranked based on their 
fold change calculated between groups of each pairwise com-
parison and analyzed by GSEA in preranked mode. We adopted 
the “classic” enrichment statistic, the recommended approach 
for RNA-sequencing data. Gene sets of interest (“GSE10239 NAI 
VE VS MEM ORY CD8 TCE LL UP,” “GSE21380 NON TFH VS GER 
MIN AL CEN TER TFH CD4 TCE LL DN,” and “GSE10239 NAI VE 
VS DAY4.5 EFF CD8 TCE LL DN”) were retrieved from the immu-
nological signatures collection (c7.all.v6.1) of the Molecular Sig-
natures Database.
Proliferation assay
CXCR5+ TIM-3–, CXCR5– TIM-3–, and CXCR5– TIM-3+, pregated 
as CD8+ Aqua–, were isolated from freshly minced tumors with a 
FAC SAria cell sorter (BD Biosciences) and stained with CellTrace 
CFSE kit (final concentration: 2 µM; Thermo Fisher) according 
to the manufacturer's protocol. Subsequently, cells were plated 
in R10 in U-bottom 96-well plates (10,000 cells/well) and stim-
ulated with either αCD3/CD28 Dynabeads (Life Technologies; 
2 beads/cell) in combination with IL-2 and IL-15 (Peprotech; 10 
ng/ml each) or IL-15 alone (50 ng/ml) for 6 and 11 d at 37°C, re-
spectively. T cells kept in low dose of IL-15 (1 ng/ml) served as 
non-proliferating, negative control. Cells were then stained with 
mAbs (Table S1) as described above. Proliferation index depicted 
in Fig. 5 D was calculated as follows: Proliferation index = MFI 
non-proliferating fraction / MFI proliferating fraction × % cells 
with diluted CFSE.
Analysis of effector molecules production
Freshly flow cytometry–sorted CXCR5+ TIM-3–, CXCR5– TIM-3–, 
and CXCR5– TIM-3+ were plated in R10 in U-bottom 96-well 
plates (10,000 cells/well) and stimulated with 10 ng/ml PMA and 
0.5 µg/ml Ionomycin (both from Sigma-Aldrich) for 3 h at 37°C 
in the presence of Golgiplug (BD Biosciences) according to the 
manufacturer’s instructions. The antibody for the detection of 
degranulation marker CD107a was added to the culture medium. 
Cells were then stained with mAbs (Table S1) as described above.
Statistical analysis
Statistical analyses were performed using GraphPad Prism ver-
sion 7, unless specified otherwise. Significance of differences for 
the frequency of single Phenograph clusters among blood, nor-
mal tissue, and tumor samples was determined using two-way 
ANO VA with Bonferroni post-hoc test. To compare distributions 
of manually gated subsets significance was determined by paired 
Wilcoxon t test, unless otherwise specified in the figure legends. 
Correlation of data were determined by calculating the Pearson 
correlation coefficient. P values <0.05 were considered statisti-
cally significant.
Online supplemental material
Fig. S1 shows the phenotypic analysis of CXCR5+ CD8+ T cells. Fig. 
S2 shows that bona fide CD8+ TSCM cells are absent in lung tu-
mors and adjacent tissues. Fig. S3 shows that the gene signature 
of CXCR5+ CD8+ T cells resembles that of both CD4+ Tfh cells and 
memory CD8+ T cells. Fig. S4 shows that proliferating CXCR5+ 
TIM-3– CD8+ T cells are self-renewing and multipotent. Table S1 
lists all of the antibodies for flow cytometry used in this study.
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